Elpiscience BioPharma and Bio-Techne announced that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the terms of the agreement, Elpiscience will have access to multiple antibodies from Bio-Techne’s extensive product portfolio for use in the development of preclinical, clinical, and commercial biopharmaceuticals. The collaboration between Elpiscience and Bio-Techne will expand mutual capabilities in the field of cancer immunotherapy.
https://thefly.com/landingPageNews.php?id=2895135
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.